Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)

Cell Death and Differentiation

Volumn 13, Issue 1, 2006, Pages 31-40

  Zuliani, C ^a   Kleber, S ^a   Klussmann, S ^a   Wenger, T ^a   Kenzelmann, M ^a   Schreglmann, N ^a   Martinez, A ^b   del Rio, J A ^b   Soriano, E ^b   Vodrazka, P ^c   Kuner, R ^c   Groene, H J ^a   Herr, I ^a   Krammer, P H ^a   Martin Villalba, A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Brain development; Branching; CD95 (Fas Apo 1); Neurite remodelling

Indexed keywords

CASPASE; FAS ANTIGEN; FAS LIGAND; TAU PROTEIN; TRANSCRIPTION FACTOR; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN DEVELOPMENT; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; EMBRYO; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NERVE CELL CULTURE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEURITE; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; CBA MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALIA;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL DIFFERENTIATION; CELLS, CULTURED; FAS LIGAND PROTEIN; HIPPOCAMPUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED CBA; MICE, MUTANT STRAINS; NEURITES; NEURONAL PLASTICITY; NEURONS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTORS;

EID: 33645006173     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401720     Document Type: Article

References (45)

1. Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, Hirt UA, Walczak H, Falk W, Essig M, Edler L, Krammer PH and Martin-Villalba A (2004) Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat. Med. 10: 389-395
2. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T and Debatin KM (1999) CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis- inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19: 3809-3817
3. Martin-Villalba A, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J and Krammer PH (2001) Therapeutic neutralization of CD95L and TNF attentuates brain damage in stroke. Cell Death Differ. 8: 679-686
4. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588
5. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794-2804
6. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH and Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798
7. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687
8. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS and Newell MK (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5: 118-125
9. Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J and Yonehara S (1998) Expression of fas antigen in the normal mouse brain. Biochem. Biophys. Res. Commun. 252: 623-628
10. Shin DH, Lee E, Kim HJ, Kim S, Cho SS, Chang KY and Lee WJ (2002) Fas ligand mRNA expression in the mouse central nervous system. J. Neuroimmunol. 123: 50-57
11. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F and Miranda RC (1999) Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: Induction of caspase-dependent cell death and activation of NF-kappaB. J. Neurosci. 19: 1754-1770
12. Cheema ZF, Santillano DR, Wade SB, Newman JM and Miranda RC (2004) The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins. BMC Neurosci. 5: 11
13. Ceccatelli S, Tamm C, Sleeper E and Orrenius S (2004) Neural stem cells and cell death. Toxicol. Lett. 149: 59-66
14. Ricci-Vitiani L, Pedini F, Mollinari C, Condorelli G, Bonci D, Bez A, Colombo A, Parati E, Peschle C and De Maria R (2004) Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J. Exp. Med. 200: 1257-1266
15. Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY and Rakic P (2001) Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci. 21: 4752-4760
16. Cohen PL and Eisenberg RA (1992) The Ipr and gld genes in systemic autoimmunity: Life and death in the Fas lane. Immunol Today 13: 427-428
17. Kovac AD, Grammig J, Mahlo J, Steiner B, Roth K, Nitsch R and Bechmann I (2002) Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (Ipr) and nondeficient mice. Eur. J. Neurosci. 16: 159-163
18. Adachi M, Watanabe-Fukunaga R and Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc. Natl. Acad. Sci. USA 90: 1756-1760
19. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA and Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
20. Cleveland DW, Hwo SY and Kirschner MW (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116: 207-225
21. Drubin DG and Kirschner MW (1986) Tau protein function in living cells. J. Cell Biol. 103: 2739-2746
22. Schneider A, Biemat J, von Bergen M, Mandelkow E and Mandelkow EM (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38: 3549-3558
23. Schwab C, DeMaggio AJ, Ghoshal N, Binder LI, Kuret J and McGeer PL (2000) Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol. Aging 21: 503-510
24. Smith HR and Steinberg AD (1983) Autoimmunity - a perspective. Ann. Rev. Immunol. 1: 175-210
25. Sakic B, Szechtman H, Denburg JA, Gomy G, Kolb B and Whishaw IQ (1998) Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-Ipr mice. J. Neuroimmunol. 87:162-170
26. Raoul C, Henderson CE and Pettmann B (1999) Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147: 1049-1062
27. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B and Tschopp J (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1: 489-495
28. Wagner U, Utton M, Gallo JM and Miller CC (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109: 1537-1543
29. Richter JD (2001) Think globally, translate locally: What mitotic spindles and neuronal synapses have in common. Proc. Natl. Acad. Sci. USA 98: 7069-7071
30. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T and Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976
31. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M and Strober W (1992) A novel lymphoproliferative/ autoimmune syndrome resembling murine Ipr/gld disease. J. Clin. Invest. 90: 334-341
32. Hess DC, Taormina M, Thompson J, Sethi KD, Diamond B, Rao R, Chamberlain CR and Feldman DS (1993) Cognitive and neurologic deficits in the MRL/ Ipr mouse: A clinicopathologic study. J. Rheumatol. 20: 610-617
33. Feinglass EJ, Amett FC, Dorsch CA, Zizic TM and Stevens MB (1976) Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 55: 323-339
34. Johnson RT and Richardson EP (1968) The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 47: 337-369
35. Denburg SD and Denburg JA (2003) Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 12: 883-890
36. Denburg JA, Carbotte RM and Denburg SD (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37: 464-467
37. Denburg SD, Carbotte RM, Ginsberg JS and Denburg JA (1997) The relationship of antiphospholipid antibodies to cognitive function in patien1ts with systemic lupus erythematosus. J. Int. Neuropsychol. Soc. 3: 377-386
38. Denburg JA, Carbotte RM and Denburg SD (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37: 464-467
39. Banker G and Goslin K (1988) Developments in neuronal cell culture. Nature 336: 185-186
40. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis- inducing ligand in vivo [see comments]. Nat. Med. 5: 157-163
41. Naldini L, Blomer U, Gage FH, Trono D and Verma IM (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93: 11382-11388
42. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L and Trono D (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72: 9873-9880
43. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279
44. Emst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, Staehler G, Kretzler M, Hollstein M and Grone HJ (2002) Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue. Am. J. Pathol. 160: 2169-2180
45. Kenzelmann M, Klaren R, Hergenhahn M, Bonrouhi M, Grone HJ, Schmid W and Schutz G (2004) High-accuracy amplification of nanogram total RNA amounts for gene profiling. Genomics 83: 550-558